Compass Financial Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Compass Financial Advisors's EXAS Position: Q2 2023 in Review
Compass Financial Advisors sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 14,967 shares — an estimated $1.01M sold.
Compass Financial Advisors first reported a position in EXAS in Q4 2021 and held it in 6 quarters. The position peaked at $1.01M in Q1 2023. 652 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.
- Compass Financial Advisors reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
- Compass Financial Advisors sold 14,967 Exact Sciences shares in Q2 2023, an estimated $1.01M.
- Compass Financial Advisors first reported a position in Exact Sciences in Q4 2021 and held it in 6 quarters.
- Compass Financial Advisors's Exact Sciences position peaked at $1.01M in Q1 2023.
- 652 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.
Based on Compass Financial Advisors's 13F filing for Q2 2023.